Vivanza Biosciences Ltd Share Price & Stock Analysis

Vivanza Biosciences Ltd (BSE: 530057) is an Ahmedabad, Gujarat-based company in the Medical Consumables industry. With a market capitalisation of ₹6 Cr, it ranks #4,966 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 14 in Medical Consumables. At ₹1.42 (as of 19 Nov 2026), the share price is 42.3% below its 52-week high of ₹2.46 and 9.2% above its 52-week low of ₹1.30. The share price is down 33.6% over one year and down 18.6% over three months.

Key Metrics

Current Price₹1.42
Market Cap₹6 Cr
BSE Code530057
SectorHealth Care > Health Care Equipment and Services > Health Care Equipment and Supplies
Sub-IndustryHealth Care Supplies > Medical Consumables
P/E Ratio14.7
Return on Equity9.48%
Return on Assets2.44%
52-Week Range₹1.30 – ₹2.46
1-Year Price Change-33.6%
3-Month Price Change-18.6%
Beta (1Y)0.35
HeadquartersAhmedabad, Gujarat
Websitevivanzabiosciences.com

Latest Quarterly Results — Q1 FY27

Revenue₹9 Cr
Net Profit₹0 Cr
Net Margin1.6%
EPS (Basic)₹0.04
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Vivanza Biosciences Ltd Quarterly Revenue and Profit Trend

Vivanza Biosciences Ltd reported revenue of ₹9 Cr in Q1 FY27, up 16.9% from ₹8 Cr in Q1 FY26 and up 59.0% from ₹6 Cr in Q4 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹0 Cr in Q1 FY26 (up 650.0%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹0 Cr (Q4 FY25) to ₹54 Cr (Q2 FY26). The company reported a net loss in 2 of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹9 Cr₹0 Cr1.6%
Q4 FY26₹6 Cr−₹0 Cr−4.7%
Q3 FY26₹45 Cr₹0 Cr0.4%
Q2 FY26₹54 Cr₹0 Cr0.9%
Q1 FY26₹8 Cr₹0 Cr0.3%
Q4 FY25₹0 Cr−₹1 Cr−570.6%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Delivery averaged 92.5% of traded volume across 16 BSE sessions (26 Oct 2026 – 19 Nov 2026).

About Vivanza Biosciences Ltd

Vivanza Biosciences Limited engages in the research, development, manufacture, and distribution of pharmaceutical products in India. It offers latex surgical and examination, and latex free examination gloves, as well as other surgical products. The company was incorporated in 1982 and is based in Ahmedabad, India.

Products and Services

1. Pharmaceuticals Related Activities-This segment engages in the trading of various pharmaceutical products.

Business Segments

1. Agro,Plastic Polymer Films and Pharmaceuticals Related Activities-100%

Vivanza Biosciences Ltd vs Peers — Medical Consumables

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Poly Medicure Ltd.₹17,162 Cr53.310.84%₹581 Cr-14.5%
Sahajanand Medical Technologies₹4,899 Cr77.9—₹373 Cr—
Q-Line Biotech Limited₹1,280 Cr15.722.63%——
Laxmi Dental Limited₹1,128 Cr39.312.77%₹80 Cr-38.2%
Prevest Denpro Ltd₹502 Cr24.617.79%—-22.6%
Choksi Imaging Ltd.₹119 Cr22.313.51%—+94.0%
GSM Foils Limited₹72 Cr3.937.54%₹97 Cr-78.3%
Mohini Health & Hygiene Ltd₹51 Crn/m-17.18%—-41.2%
Vivanza Biosciences Ltd₹6 Cr14.79.48%₹9 Cr-33.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Vivanza Biosciences Ltd?

Vivanza Biosciences Ltd is trading at ₹1.42, with a market capitalisation of ₹6 Cr.

Which sector does Vivanza Biosciences Ltd belong to?

Vivanza Biosciences Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).

What are the key financial ratios of Vivanza Biosciences Ltd?

Vivanza Biosciences Ltd has a P/E of 14.7 and a return on equity of 9.48%.

What is the stock symbol of Vivanza Biosciences Ltd?

Vivanza Biosciences Ltd is listed on the BSE under the scrip code 530057.

How has Vivanza Biosciences Ltd's share price moved over the past year?

Vivanza Biosciences Ltd's share price is down 33.6% over one year and down 18.6% over three months. Its 52-week range is ₹1.30 to ₹2.46.

What were Vivanza Biosciences Ltd's latest quarterly results?

In Q1 FY27, Vivanza Biosciences Ltd reported revenue of ₹9 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.04 (standalone, parsed from the company's exchange filing).

How have Vivanza Biosciences Ltd's revenue and profit changed over the past year?

Vivanza Biosciences Ltd reported revenue of ₹9 Cr in Q1 FY27, up 16.9% from ₹8 Cr in Q1 FY26 and up 59.0% from ₹6 Cr in Q4 FY26.

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.